| California |
77-0220697 | |
| (State or other jurisdiction of incorporated or organization) |
(I.R.S. Employer Identification
No.) |
| 880 Maude Avenue, Suite A, Mountain View, California |
94043 | |
| (Address of principal executive office) |
(Zip Code) |
| Page | ||||
| Part I.
Financial Information |
3 | |||
| Item 1. |
3 | |||
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 | ||||
| Item 2. |
11 | |||
| Item 3. |
15 | |||
| Item 4. |
15 | |||
| Part II.
Other Information |
16 | |||
| Item 1. |
16 | |||
| Item 2. |
16 | |||
| Item 3. |
16 | |||
| Item 4. |
16 | |||
| Item 6. |
16 | |||
| 17 | ||||
| Three Months Ended September 30, |
Six Months Ended September 30, |
|||||||||||||||
| 2002 |
2001 |
2002 |
2001 |
|||||||||||||
| (000s omitted, except per share data) |
||||||||||||||||
| Sales: |
||||||||||||||||
| Product sales |
$ |
414 |
|
$ |
1,272 |
|
$ |
2,249 |
|
$ |
2,927 |
| ||||
| License sales |
|
275 |
|
|
|
|
|
275 |
|
|
|
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Net sales |
$ |
689 |
|
$ |
1,272 |
|
$ |
2,524 |
|
$ |
2,927 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Costs and expenses: |
||||||||||||||||
| Cost of sales |
|
191 |
|
|
543 |
|
|
1,289 |
|
|
1,499 |
| ||||
| Research and development |
|
|
|
|
103 |
|
|
|
|
|
388 |
| ||||
| Selling, general, and administrative |
|
546 |
|
|
1,192 |
|
|
1,179 |
|
|
1,993 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Total costs and expenses |
|
737 |
|
|
1,838 |
|
|
2,468 |
|
|
3,880 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Operating income (loss) |
|
(48 |
) |
|
(566 |
) |
|
56 |
|
|
(953 |
) | ||||
| Interest and other income, net |
|
57 |
|
|
572 |
|
|
1,658 |
|
|
1,008 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Income before income tax provision |
|
9 |
|
|
6 |
|
|
1,714 |
|
|
55 |
| ||||
| Income tax provision (benefit) |
|
(165 |
) |
|
|
|
|
(165 |
) |
|
2 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Net income |
$ |
174 |
|
$ |
6 |
|
$ |
1,879 |
|
$ |
53 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Basic net income per share |
$ |
0.01 |
|
$ |
0.00 |
|
$ |
0.16 |
|
$ |
0.00 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Diluted net income per share |
$ |
0.01 |
|
$ |
0.00 |
|
$ |
0.16 |
|
$ |
0.00 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Shares used in computing basic per share amounts |
|
11,634 |
|
|
11,634 |
|
|
11,634 |
|
|
11,634 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Shares used in computing diluted per share amounts |
|
11,634 |
|
|
11,634 |
|
|
11,634 |
|
|
11,634 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| September 30, 2002 |
March 31, 2002 | |||||
| (000s omitted) | ||||||
| Assets |
||||||
| Current assets |
||||||
| Cash and cash equivalents |
$ |
14,804 |
$ |
14,332 | ||
| Short-term investments |
|
8 |
|
3,347 | ||
| Accounts receivable, net |
|
59 |
|
182 | ||
| Inventories |
|
|
|
258 | ||
| Other current assets |
|
441 |
|
799 | ||
| |
|
|
| |||
| Total current assets |
|
15,312 |
|
18,918 | ||
| Property and equipment, net |
|
16 |
|
35 | ||
| Other assets |
|
287 |
|
287 | ||
| |
|
|
| |||
| Total assets |
$ |
15,615 |
$ |
19,240 | ||
| |
|
|
| |||
| Liabilities and Shareholders Equity |
||||||
| Current liabilities |
||||||
| Accounts payable |
$ |
59 |
$ |
88 | ||
| Accrued expenses |
|
227 |
|
607 | ||
| Accrued employee expenses |
|
102 |
|
326 | ||
| Deferred tax liability |
|
|
|
65 | ||
| |
|
|
| |||
| Total current liabilities |
|
388 |
|
1,086 | ||
| Shareholders equity: |
||||||
| Preferred stock, no par value: |
||||||
| Authorized shares 5,000 |
||||||
| No shares issued or outstanding |
|
|
|
| ||
| Common stock, no par value: |
||||||
| Authorized shares 50,000 |
||||||
| Issued and outstanding shares 11,634 at September 30, 2002 and March 31, 2002 |
|
15,053 |
|
15,597 | ||
| Accumulated other comprehensive income |
|
|
|
2,557 | ||
| Retained earnings |
|
174 |
|
| ||
| |
|
|
| |||
| Total shareholders equity |
|
15,227 |
|
18,154 | ||
| |
|
|
| |||
| Total liabilities and shareholders equity |
$ |
15,615 |
$ |
19,240 | ||
| |
|
|
| |||
| Six Months Ended September 30, |
||||||||
| 2002 |
2001 |
|||||||
| (000's omitted) |
||||||||
| Operating Activities: |
||||||||
| Net income |
$ |
1,879 |
|
$ |
53 |
| ||
| Adjustments: |
||||||||
| Depreciation |
|
19 |
|
|
149 |
| ||
| Impairment on short-term investments |
|
12 |
|
|
|
| ||
| Gain on Tripath Technology distribution |
|
(1,544 |
) |
|
|
| ||
| Changes in assets and liabilities: |
||||||||
| Accounts receivable |
|
123 |
|
|
255 |
| ||
| Inventories |
|
258 |
|
|
551 |
| ||
| Other assets |
|
358 |
|
|
(376 |
) | ||
| Accounts payable |
|
(29 |
) |
|
54 |
| ||
| Accrued expenses |
|
(380 |
) |
|
(61 |
) | ||
| Accrued employee expenses |
|
(224 |
) |
|
|
| ||
| |
|
|
|
|
| |||
| Net cash provided by operating activities |
|
472 |
|
|
625 |
| ||
| Investing Activities: |
||||||||
| Purchase of property and equipment |
|
|
|
|
(34 |
) | ||
| Purchase of short-term investments |
|
|
|
|
(413 |
) | ||
| |
|
|
|
|
| |||
| Net cash used in investing activities |
|
|
|
|
(447 |
) | ||
| Financing Activities: |
||||||||
| Net cash used in financing activities |
|
|
|
|
|
| ||
| |
|
|
|
|
| |||
| Net increase in cash and cash equivalents |
|
472 |
|
|
178 |
| ||
| Cash and cash equivalents beginning of period |
|
14,332 |
|
|
11,758 |
| ||
| |
|
|
|
|
| |||
| Cash and cash equivalents end of period |
$ |
14,804 |
|
$ |
11,936 |
| ||
| |
|
|
|
|
| |||